ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 57 filers reported holding ONCOCYTE CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $352,000 | -82.1% | 162,300 | -70.7% | 0.00% | -75.0% |
| Q3 2021 | $1,970,000 | -36.1% | 553,324 | +3.0% | 0.00% | -42.9% |
| Q2 2021 | $3,083,000 | +40.9% | 537,121 | +27.4% | 0.01% | +16.7% |
| Q1 2021 | $2,188,000 | +504.4% | 421,542 | +122.3% | 0.01% | +200.0% |
| Q2 2020 | $362,000 | +1031.2% | 189,649 | +1358.8% | 0.00% | – |
| Q1 2020 | $32,000 | -27.3% | 13,000 | -37.8% | 0.00% | – |
| Q3 2019 | $44,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $25,851,000 | 1.86% |
| Defender Capital, LLC. | 2,562,130 | $4,001,000 | 1.39% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $18,214,000 | 0.59% |
| Penbrook Management LLC | 578,150 | $861,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $492,000 | 0.52% |
| Orbimed Advisors | 3,493,800 | $5,206,000 | 0.08% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $112,000 | 0.07% |
| Fort Sheridan Advisors LLC | 135,000 | $201,000 | 0.06% |
| AWM Investment Company, Inc. | 241,867 | $360,000 | 0.05% |
| WEALTH EFFECTS LLC | 49,000 | $73,000 | 0.03% |